Work

Longer Follow-Up Confirms a Low Relapse Rate after Non-Myeloablative Allogeneic Transplantation (NMT) for Non-Hodgkin’s Lymphoma (NHL), Including Patients with PET or Gallium-Avid Disease.

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.44.44

Authors: Issa F. Khouri, Rima M. Saliba, Ming-Sheng Lee, Grace-Julia Okoroji, Luis Fayad, Farzaneh Maadani, Chitra Hosing, Barry Samuels, Sergio Giralt, Marcos de Lima, Barbara Pro, Anas Younes, Peter McLaughlin, Larry Kwak, Richard E. Champlin

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558781996

FWCI: 0.779

Cites:

Cited by: 4

Related to: 10